I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ISPOR Europe 2025

-
Coming soon
04:00 PM
Duration 180mins Glasgow, UK
Considerations for modelling caregiver spillover within economic evaluations for neurological disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD) and Multiple Sclerosis (MS)
Eric Ngonga Kemadjou, C Simone Sutherland, Chui-ying Yip, Katya Galactionova

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:00 PM
Duration 60mins Glasgow, UK
Payer and HTA Evaluation Criteria and Considerations for Coverage and Reimbursement of Patient Self-Monitoring Technology
Malyon A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 180mins Glasgow, UK
Significant burden of chronic obstructive pulmonary disease (COPD) on health status and well-being persists among patients experiencing one severe or two or more moderate exacerbations of COPD and their caregivers
Denise M Boudreau, Johannes Ammann, Joanna de Courcy, Jacob Devine, Paul Hernandez, Claudio Micheletto, Jennifer Quint, Katerina Samara, Tonya Winders, Per-Olof Thuresson

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 180mins Glasgow, UK
Long-Term Economic Impact of Non-Persistence to Disease Modifying Therapies in a Cohort of German Patients with Multiple Sclerosis
Braune, Stefan; Bergmann, Arnfin; Heer, Yanic; Bianca Jarecki, Jana; Muros-Le Rouzic, Erwan; Sun, Diana; Athanasios, Siadimas

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:00 AM
Duration 60mins Glasgow, UK
Optimizing MASLD Diagnostic Protocols: A Microsimulation Analysis of Test Sensitivity Requirements
Garay OU

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 assay as part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Garay OU

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Cost-Effectiveness Analysis of GAAD Algorithm for Hepatocellular Carcinoma Surveillance of Cirrhotic Patients using Italian Real-World Data
Porta C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Budget Impact of Introducing Accu-Chek SmartGuide Real-Time Continuous Glucose Monitoring (rtCGM) solution for Diabetes Management in Portugal
Torres J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Cross-validation of the glycated haemoglobin (HbA1c) Translator: a predictive tool to evaluate the relationship between diabetes complications and associated healthcare costs
Garay OU

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Procalcitonin-Guided Antimicrobial Stewardship for Sepsis and Lower Respiratory Tract Infections: A Budget Impact Analysis for the Perspective of the Patients in India
Angadi E

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:00 AM
Duration 150mins Glasgow, UK
Reducing the transmission and annual burden of influenza in the UK with baloxavir marboxil▼: A cost-effectiveness analysis using evidence from the CENTERSTONE trial
Kommandantvold SA

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar